Yuri Yamashita1, Takahiro Yamada3, Ohsuke Migita4, Satoshi Ohnishi5, Hirofumi Ohashi6, Risa Nonaka2, Kinji Ohno7, Gen Nishimura8, Shiro Ikegawa8, Nobutaka Hattori1, Eri Hirasawa1 (1.Department of Neurology, Juntendo University School of Medicine, 2.Department of Diagnosis, Prevention and Treatment Dementia, Graduate School of Medicine, Juntendo University, 3.Clinical Genetics Unit, Kyoto University Hospital, 4.Department of Pediatrics, St. Marianna University School of Medicine, 5.Department of Neonatology, Osaka City General Hospital, 6.Division of Genetics, Saitama Children's Medical Center, 7.Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 8.Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences)
Session information
Oral Session
[O-22] Care for intractable diseases and others1
Thu. May 23, 2019 9:45 AM - 10:45 AM Room 12 (Osaka International Convention Center 11F Conference Room 1101-1102)
Chair:Shigeki Arawaka(Department of Internal Medicine IV, Division of Neurology, Osaka Medical College)
Hiroyuki Kato, Ritsuo Hashimoto, Tomoko Ogawa, Mieko Otsuka, Tomohiro Suzuki (Neurology, International University of Health and Welfare Hospital)
Eri Sano1, Hiroki Tani1, Koji Nagai2, Takafumi Hosokawa1, Shimon Ishida1, Tohru Takeuchi2, Shigeki Arawaka1 (1.Dept. Neurology, Osaka medical college, 2.Dept. Rheumatology, Osaka medical college)
Keiji Chida1, Masaaki Konagaya2, Shuji Hashimoto3 (1.Department of Neurology, NHO Iwate Hospital, 2.Department of Neurology, NHO Suzuka Hospital, 3.Department of Hygiene, Fujita Health University School of Medicine)